目的 统计分析2019—2021年安徽中医药大学神经病学研究所附属医院第二类精神药品使用情况。方法 收集2019年1月—2021年12月安徽中医药大学神经病学研究所附属医院第二类精神药品用药处方，具体对其销售金额、用药频度（DDDs）、限定日费用（DDC）及排序比（B/A）等指标进行统计和分析。结果 2019—2021年医院第二类精神药品销售金额呈逐年升高趋势，氯硝西泮、右佐匹克隆、唑吡坦用药频度（DDDs）始终位居前3位。第二类精神药品DDC值基本保持稳定，略有上涨。DDC值均＜4元。销售金额与用药人数同步性良好。结论 安徽中医药大学神经病学研究所附属医院第二类精神药品处方结构基本合理，但仍需加强管理干预，确保医师规范用药，以提高药物疗效及安全性。

Objective To statistically analyze the use of class II psychotropic drugs in the Affiliated Hospital of the Institute of Neurology, Anhui University of Traditional Chinese Medicine from 2019 to 2021. Methods The class II psychotropic drugs were collected from Affiliated Hospital of the Institute of Neurology, Anhui University of Traditional Chinese Medicine from January 2019 to December 2021, and the consumption sum, DDDs, DDC, and B/A were statistically analyzed. Results From 2019 to 2021, the retail amount of class II psychotropic drugs increased year by year, with the frequency (DDDs) of clonazepam, dozopclone, and zolpidem always ranked the top three. The DDC value of class II psychotropic drugs remained stable and increased slightly. DDC values were all less than 4 yuan. The consumption sum had good synchronization with the number of drug users. Conclusion The prescription structure of the class II psychotropic drugs in Affiliated Hospital of the Institute of Neurology, Anhui University of Traditional Chinese Medicine is basically reasonable, but it is still necessary to strengthen management intervention to ensure that doctors standardize drug use, so as to improve the efficacy and safety of drugs.

R971